Partner And Chair Of Antitrust Group
CurrentFor more than 25 years, I have obtained antitrust clearance for large and complex strategic mergers, tried monopolization and patent jury cases, arbitrated international commercial disputes and, most importantly, developed relationships with some of the best companies in the world. I have been recognized by Chambers USA and several other publications for my work. Clients value my business-oriented approach to transactions and commercial disputes and my ability and willingness to give quick and clear guidance. A substantial part of my work involves the intersection of antitrust and intellectual property. Recent antitrust work on strategic transactions includes Take-Two’s $12 billion acquisition of Zynga; Dell’s $67 billion acquisition of EMC, and Dell’s $2 billion sale of Boomi; Tyson Foods’ acquisition of Williams Country Sausage, and Tyson’s sale of its pet treats business to General Mills; Cummins Inc.’s acquisitions of Jacobs Vehicles Systems and Faurecia’s emissions businesses; Interactive Data Corporation’s $5 billion acquisition by Intercontinental Exchange Inc.; Thermo Fisher Scientific's $13.6 billion acquisition of Life Technologies; SunGard in its $9 billion sale to Fidelity National; Tyler Technologies in its acquisition of New World Systems; A&P in its acquisition of Pathmark Stores; Take-Two Interactive Software in Electronic Arts' hostile bid for Take-Two; GameStop's acquisition of Electronics Boutique; Harcourt, Inc.'s acquisition by Reed Elsevier and Thomson.Where mergers have been challenged, I have tried and prevailed in multiple cases, including: the Antitrust Division's challenge to SunGard/Comdisco; the Antitrust Division's challenge to the sale by Tyson Foods of a poultry processing complex to George's Foods, and the City of New York's challenge to the combination of health insurers GHI and HIP to form Emblem Health.When patent cases involve monopoly or FRAND issues, I advise and litigate in the federal courts and the ITC.
